Figure S5 from <i>CDKN2A/p16</i> Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition

Mayur A. Gadhikar,Jiexin Zhang,Li Shen,Xiayu Rao,Jing Wang,Mei Zhao, Nene N. Kalu,Faye M. Johnson,Lauren A. Byers,John Heymach, Walter N. Hittelman,Durga Udayakumar,Raj K. Pandita,Tej K. Pandita,Curtis R. Pickering,Abena B. Redwood,Helen Piwnica-Worms,Katharina Schlacher,Mitchell J. Frederick, Jeffrey N. Myers

crossref（2023）

引用 0|浏览4

暂无评分

摘要

This file contains data showing impact of roscovitine co-treatment on the cell cycle responses of hypersensitive cells following Chk1 inhibition and a theoretical model explaining basis for prexasertib sensitivity in HNSCC cells. This file is linked to main figure 6.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Figure S5 from &lt;i&gt;CDKN2A/p16&lt;/i&gt; Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition

Figure S5 from <i>CDKN2A/p16</i> Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition